IFNA1 and COVID-19: Although there have been several therapeutic regimens in COVID‐19 patients, such as IFN‐alpha, lopinavir/ritonavir (Kaletra), chloroquine phosphate, and Ribavirin,21, 32 in immunocompromised patients such as renal transplant recipients, Lopinavir/Ritonavir (Kaletra) (protease inhibitors) was the most commonly prescribed medication.34